US FDA OKs Maha lab’s liquid biopsy to detect cancer

A Nashik-based cancer laboratory on Friday announced that the US Food and Drug Administration (US FDA) has granted a “breakthrough device designation” for its liquid biopsy test to detect early-stage breast cancer.

from Mumbai News: Latest Mumbai News Headlines & Coronavirus News Updates from Mumbai - Times of India https://ift.tt/3Fp4VTk
via IFTTT